pLKO.1C Citations (7)

Originally described in: Improved third-generation lentiviral packaging with pLKO.1C vectors.
Lee S, Cobrinik D Biotechniques. 2020 Jun;68(6):349-352. doi: 10.2144/btn-2019-0155. Epub 2020 Mar 6. PubMed Journal

---

Articles Citing pLKO.1C

Articles
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis. Chen D, Ji F, Zhou Q, Cheung H, Pan Y, Lau HC, Liang C, Yang Z, Huang P, Wei Q, Cheung AH, Kang W, Chen H, Yu J, Wong CC. Cancer Res. 2024 Sep 4;84(17):2856-2872. doi: 10.1158/0008-5472.CAN-23-2081. PubMed
ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt Pathway. Rodvold JJ, Grimmer M, Ruiz K, Marsters SA, Oikonomidi I, Tan-Aristy E, Pham VC, Sarkar T, Harnoss JM, Shatz-Binder W, Modrusan ZD, Wu TD, Lill JR, Villemure E, Rudolph J, de Sousa E Melo F, Ashkenazi A. Cancer Res Commun. 2024 Oct 1;4(10):2734-2755. doi: 10.1158/2767-9764.CRC-24-0268. PubMed
Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer. Morillo-Huesca M, G Lopez-Cepero I, Conesa-Bakkali R, Tome M, Watts C, Huertas P, Moreno-Bueno G, Duran RV, Martinez-Fabregas J. J Exp Clin Cancer Res. 2025 Feb 27;44(1):74. doi: 10.1186/s13046-025-03334-6. PubMed
Targeting the Glucose-Insulin Link in Head and Neck Squamous Cell Carcinoma Induces Cytotoxic Oxidative Stress and Inhibits Cancer Growth. Mazambani S, Park SH, Choe JH, Nguyen AH, Lee BS, Jeong JY, Lee SY, Kim CH, Park YI, Padilla J, Lee J, Thotala D, Oh TG, Singh PK, Hur H, Hur JK, Kim JW, Kim TH. Cancer Res Commun. 2025 Jun 1;5(6):921-938. doi: 10.1158/2767-9764.CRC-23-0506. PubMed
SRSF9 Forms Phase-Separated Condensates to Promote Ovarian Cancer Progression by Inducing RNA Alternative Splicing That Is Inhibited by m6A Modification. Zuo X, Xu J, Yang D, Yang C, Liu X, Chen N, Wang H, Luo X, Luo Q, Wang Y, Wei Q, Yang Y, Zhao H, Xu J, Wang W, Liu T, Yi P. Cancer Res. 2025 Oct 15;85(20):3894-3909. doi: 10.1158/0008-5472.CAN-24-4233. PubMed
SAICAR Drives T Regulatory Cell Differentiation and FOXP3 Maintenance to Promote Immunotherapy Resistance. Li M, Chen Y, Liu A, Wu Q, Huang C, Song D, Hu F, Lan J, Huang C, Hu J, Wang G. Cancer Res. 2026 May 4;86(9):2218-2236. doi: 10.1158/0008-5472.CAN-25-4373. PubMed
Downregulation of PIEZO1 Activity Promotes Breast Cancer Cell Survival under Shear Stress by Modulating beta-Catenin and BCL2. Dattachoudhury S, Sharma A, Sharma R, Pal S, Sukumar P, Jaganathan BG. Cancer Res Commun. 2026 Jul 1;6(7):1557-1572. doi: 10.1158/2767-9764.CRC-25-0749. PubMed

If you have published an article using this material, please email us at to have your article added to this page.